医疗机构外送检验检测风险识别与规范化防控策略^*

Risk Identification and Standardized Prevention and Control Strategies for Outsourced Laboratory Testing in Healthcare Institutions

摘要

随着我国医疗卫生事业高质量发展，医疗机构外送检验检测已成为弥补诊疗资源短板、提供精准诊疗服务的重要补充形式。本文立足医疗机构外送检验检测管理实践，系统识别外送检验检测在法律、伦理、管理等方面风险，深入剖析风险产生的根源，并结合卫生健康行政部门相关监管要求，有针对性地提出防控策略，旨在规范医疗机构外送检验检测行为，防范医疗安全与廉洁风险，保障患者合法权益，维护医疗行业公益性与公信力。

Abstract

With the high-quality development of China's medical and health care industry, the outsourcing of laboratory examinations by health care institutions has become an important supplementary approach to alleviate the shortage of medical resources and provide precise medical services. Drawing on management practices for outsourced laboratory examinations, this article systematically identifies legal, ethical, and management risks in outsourced laboratory testing, deeply analyzes the root causes of these risks, and in combination with the relevant regulatory requirements of health and wellness administrative departments, proposes targeted prevention and control strategies, The goal is to standardize the outsourcing of laboratory testing by health care institutions, prevent medical safety and integrity risks, protect patients' legitimate rights and interests, and maintain the public welfare and credibility of the medical industry.

关键词

医疗机构 / 外送检验检测 / 风险分析 / 防控策略

Key words

Medical institutions / Outsourced laboratory examinations / Risk analysis / Prevention and control strategies

参考文献

[1] 李艳, 黄萱. 第三方实验室开展标准化质量管理与质量控制的实践研究[J]. 中国医药科学, 2018, 8(20): 245-248. DOI: 10.3969/j.issn.2095—0616.2018.20.074.

[2] Li Y, Huang X. Practical research on standardization quality management and quality control in third—party laboratories[J]. China Medicine and Pharmacy, 2018, 8(20): 245-248. DOI: 10.3969/j.issn.2095—0616.2018.20.074.

[3] 张誉凡, 黄天泓, 王天龙, 等 . 军队大型三甲医院规范外送检测服务的思考[J]. 东南国防医药, 2022, 24(3): 322-324. DOI: 10.3969/j.issn.1672—271X.2022.03.022.

[4] 林蕾, 叶梅毅, 李祖平, 等 . 县级区域医学检验中心对基层医疗卫生机构检验能力与质量提升的调查分析[J]. 中国农村卫生, 2024, 16(8): 36-39. DOI: 10.20126/j.cnki.1674—361X.2405—065.

[5] 范维肖, 曾宪飞, 郝晓柯, 等 . 区域医学检验中心在提升基层医疗机构临床微生物检测水平中的作用[J]. 检验医学, 2022, 37(12): 1122-1124. DOI: 10.3969/j.issn.1673—8640.2022.12.004.

[6] 黄莺. 第三方医学检验机构法律问题研究—从两个典型判例的实证研究切入[J]. 医学与哲学, 2022, 43(7): 58-62. DOI: 10.12014/j.issn.1002—0772.2022.07.12.

[7] Huang Y. Study on legal issues of third—party medical testing institutions: On the empirical study of two judicial precedents[J]. Medicine and Philosophy, 2022, 43(7): 58-62. DOI: 10.12014/j.issn.1002—0772.2022.07.12.

[8] 法学学术前沿. 第三方核酸检测机构漏检造假行为的刑事责任[EB/OL]. (2022—05—31)[2026—07—15]. https://mp.weixin.qq.com/s/AN2Z4C36E9rhdio1RP—w_g.

[9] 金域医学: 以质量为先强内核, 以创新驱动谋发展[J]. 中国质量, 2021(12): 12-13.

[10] 宋颂, 朱亚捷, 杨光华, 等. 上海市第三方医学检验机构联合监管结果分析[J]. 中国卫生监督杂志, 2019, 26(4): 332-335. DOI: 10.3969/j.issn.1007—6131.2019.04.005.

[11] Song S, Zhu Y J, Yang G H, et. al. Analysis of joint supervision results of the independent clinical laboratory in Shanghai[J]. Chinese Journal of Health Inspection, 2019, 26(4): 332-335. DOI: 10.3969/j.issn.1007—6131.2019.04.005.

[12] 李志明, 何建凡, 冼慧霞, 等. 深圳市第三方检验检测技术服务机构新型冠状病毒核酸检测能力调查与评估[J]. 中国公共卫生管理, 2022, 38(6): 868-870. DOI: 10.19568/j.cnki.23—1318.2022.06.0040.

[13] Li Z M, He J F, Xian H X, et. al. Investigation and evaluation of COVID—19 nucleic acid detection capability in third—party inspection and testing technology service institutions in Shenzhen City[J]. Chinese Journal of Public Health Management, 2022, 38(6): 868-870. DOI: 10.19568/j.cnki.23—1318.2022.06.0040.

[14] 邓勇 . 公立医院牵手第三方医学实验室: 机遇与挑战[J]. 中国医院院长, 2023, 19(6): 86-89.

[15] 金正伟, 罗惠明, 余智超. 保存温度和时间对外送标本检测影响的评估[J]. 中外医学研究, 2014, 12(22): 50-52. DOI: 10.14033/j.cnki.cfmr.2014.22.011.

[16] Jing Z W, Luo H M, Yu Z C. Evaluation on the effect of temperature and time for delivery specimens[J]. Chinese and Foreign Medical Research, 2014, 12(22): 50-52. DOI: 10.14033/j.cnki.cfmr.2014.22.011.

[17] 黄锦玲, 蒋璐岑, 朱晓菁, 等. 基于大型公立医院巡查的对外委托医学检测服务管理实践[J]. 现代医院管理, 2025, 23(5): 19-22. DOI: 10.3969/j.issn.1672—4232.2025.05.005.

[18] Huang J L, Jiang L C, Zhu X J, et. al. Management practice of outsourced medical testing services based on inspection of large public hospitals[J]. Modern Hospital Management, 2025, 23(5): 19-22. DOI: 10.3969/j.issn.1672—4232.2025.05.005.

[19] 耿明浩, 赵航宇, 李迎丽, 等. 新形势下我国第三方检验机构应对之道[J]. 检验检疫学刊, 2019, 29(1): 61-63.

[20] Geng M H, Zhao H Y, Li Y L, et. al. The response of third—party inspection agencies in China under the new situation[J]. Quality Safety Inspection and Testing, 2019, 29(1): 61-63.

[21] 吴红霞, 祖燕, 朱显昀, 等. 河南省医学检验实验室依法执业现状调查[J]. 中国卫生监督杂志, 2022, 29(1): 51-56. DOI: 10.3969/j.issn.1007—6131.2022.01.010.

[22] Wu H X, Zu Y, Zhu X Y, et. al. Survey on the current practicing in accordance with the law of Henan province medical laboratories[J]. Chinese Journal of Health Inspection, 2022, 29(1): 51-56. DOI: 10.3969/j.issn.1007—6131.2022.01.010.

[23] 马尚玉, 霍增辉. 第三方核酸检测机构不法行为及社会共治对策[J]. 中国卫生法制, 2024, 32(2): 8-14. DOI: 10.19752/j.cnki.1004—6607.2024.02.002.

[24] Ma S Y, Huo Z H. Wrongful acts of independent clinical laboratory and countermeasures of social co—governance[J]. Health Law, 2024, 32(2): 8-14. DOI: 10.19752/j.cnki.1004—6607.2024.02.002.

[25] 武迎慧, 苗国梅, 徐艳玲, 等. 公立医院腐败现状与法律建议—基于裁判文书网2016个卫生刑事司法判决文书数据分析[J]. 中国卫生事业管理, 2023, 40(3): 193-197.

[26] Wu Y H, Miao G M, Xu Y L, et. al. Study on the status of corruption in public hospitals and its legal suggestions basedon data analysis of 2016 health criminal judicial judgment documents from the Judgment Documents Network[J]. Chinese Health Service Management, 2023, 40(3): 193-197.

[27] 曾子芮 . 医疗反腐纵深推进: 精准性打击, 全链条治理[J]. 廉政瞭望, 2025(22): 38-39.

[28] 吕俊锋 . 基于信息系统的对外委托医疗项目管理机制探索—以浙江省某三甲医院为例[J]. 现代商贸工业, 2020, 41(35): 63-64. DOI: 10.19311/j.cnki.1672—3198.2020.35.029.

[29] 江西省九江市纪委监委调研组 . 从地方实践看医疗卫生领域腐败问题治理[J]. 中国纪检监察, 2023(8): 57.

[30] 罗一捷, 陈玥, 廖燕, 等. 第三方医学实验室合规运营与政策实践: 中国法规框架下的关键要点分析[J]. 华西医学, 2025, 40(11): 1839-1842. DOI: 10.7507/1002—0179.202508024.

[31] Luo Y J, Chen Y, Liao Y, et. al. Compliance operation and policy practice of third—party medical laboratories: key points analysis under China's regulatory framework[J]. West China Medical Journal, 2025, 40(11): 1839-1842. DOI: 10.7507/1002—0179.202508024.

[32] 文志林, 许明磊, 徐丽军, 等. 医院外送第三方实验室检验的管理实践[J]. 中国医疗器械杂志, 2023, 47(4): 459-463. DOI: 10.3969/j.issn.1671—7104.2023.04.021.

[33] Wen Z L, Xu M L, X L L J, et al. Management practice of outsourcing hospital tests to independent clinical laboratories[J]. Chinese Journal of Medical Instrumentation, 2023, 47(4): 459-463. DOI: 10.3969/j.issn.1671—7104.2023.04.021.

[34] 周吉银, 徐玉梅. 《赫尔辛基宣言》中强化生物样本伦理治理及启示[J]. 医学与哲学, 2025, 46(14): 28-32. DOI: 10.12014/j.issn.1002—0772.2025.14.06.

[35] Zhou J Y, Xu Y M. Strengthening ethical governance of biospecimens in Declaration of Helsinki and its implications[J]. Medicine and Philosophy, 2025, 46(14): 28-32. DOI: 10.12014/j.issn.1002—0772.2025.14.06.

基金资助

*2024年四川医事卫生法治研究中心立项项目(YF24-Y03)